Apax Partners to seal 3.5x return selling Neuraxpharma to Permira – sources
Apax Partners is set for a 3.5x return selling its stake in European pharma company Neuraxpharm to fellow private equity major Permira, AltAssets has learned.
Apax Partners is set for a 3.5x return selling its stake in European pharma company Neuraxpharm to fellow private equity major Permira, AltAssets has learned.
The founder of buyout house Hauser Private Equity is facing up to six months in prison after pleading guilty to taking part in the extensive US college admissions scandal by paying $40,000 to rig his
The Swedish private equity firm and the UK residential specialist plan to have a portfolio of around 3,000 affordable homes in London, expected to be built and completed over a period of at least five
Open banking company TrueLayer has added another $25m to its coffers by tapping its existing investors for another cash injection.
London finance workers are spending hundreds of pounds on Covid-19 tests offered by private doctors across the Square Mile
Hopes rise that tech offerings could spark a wider revival following strong debut by UK's online retailer THG Holdings
Uruguay-based dLocal, which helps international companies process payments in emerging markets, raised $200m in a growth-equity financing round led by General Atlantic
Laxman Pai, Opalesque Asia: CoinFund, a private crypto asset investor and blockchain research, and advisory firm, announced that Evan Feng has joined its investment research team. "Evan brings to us his experiences...Article Link
Posted by Hal S. Scott (Harvard Law School) and John Gulliver (Program on International Financial Systems), on Monday, September 21, 2020 Editor's Note: Hal S. Scott is the Emeritus Nomura Professor of International Financial Systems
In its revised global outlook, the lender's economists also warned that the increase in public debt could precipitate another financial crisis
